Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Skin Care × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Lymphedema 1 Breast Neoplasms 1

Interventions

Cyclophosphamide 1274 Cisplatin 1214 Radiotherapy 1148 Paclitaxel 1135 Carboplatin 1076 Gemcitabine 1048 Docetaxel 979 Bevacizumab 911 Fluorouracil 768 Doxorubicin 689 Capecitabine 655 Dexamethasone 645 Rituximab 635 Oxaliplatin 601 Etoposide 578 pembrolizumab 565 Irinotecan 551 Filgrastim 540 Cytarabine 504 Leucovorin 499 Nivolumab 480 Vincristine 438 Bortezomib 412 Cetuximab 411 Prednisone 406 Trastuzumab 398 Erlotinib Hydrochloride 398 Surveys and Questionnaires 390 Methotrexate 370 Lenalidomide 364

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02609724 2022-03-17

EFforT-BCRL

Universitaire Ziekenhuizen KU Leuven

Phase NA Completed

194 enrolled 19 charts

Breast Neoplasms, Lymphedema

Data powered by HemOnc (CC BY 4.0) Colophon ⚡